AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks

Psychopharmacology

Volumn 126, Issue 3, 1996, Pages 249-259

  Stephens, D N ^a   Cole, B J ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b BAYER PHARMA AG   (Germany)

Author keywords

AMPA antagonists; Delayed matching; DRL responding; Glutamate receptors; GYKI 52466; MK 801; NBQX

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; TASK PERFORMANCE;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; N-METHYLASPARTATE; QUINOXALINES; RATS; RATS, WISTAR; REINFORCEMENT (PSYCHOLOGY);

EID: 0029898198     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246455     Document Type: Article

References (57)

1. Baddeley AD (1981) The concept of working memory: a review of its current state and probable future development. Cognition 10:17-23
2. Balster RL, Baird JB (1979) Effects of phencyclidine, d-amphetamine and pentobarbital on spaced responding in mice. Pharmacol Biochem Behav 11:617-623
3. Balster RL, Wessinger WD (1983) Central nervous depressant effects of phencyclidine. In: Kamenka J-M, Domino EF, Geneste P (eds) Phencyclidine and related arylcyclohexylamines: present and future applications. NPP Books, Ann Arbor, Michigan, pp 231-309
4. Bennett DA, Bernard PS, Amrick CL, Wilson DE, Liebman JM, Hutchison AJ (1989) Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 250:454-460
5. Boast CA, Pastor G, Gerhardt SC, Hall NR, Liebman JM (1988) Behavioral tolerance and sensitization to CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 247:556-561
6. Carter AJ (1992) Glycine antagonists: regulation of the NMDA receptor complex by the strychnine insensitive glycine site. Drugs Future 17:595-613
7. Carter C, Benavides J, Legendre P, Vincent JD, Noel F, Thuret F, Lloyd KG, Arbilla S, Zivkovic B, MacKenzie ET, Scatton B, Langer SZ (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. J Pharmacol Exp Ther 247:1222-1232
8. Cervo L, Samanin R (1995) Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res 673:242-250
9. Cole BJ, Hillmann M (1994) Effects of benzodiazepine receptor ligands on the performance of an operant delayed matching to position task in rats: opposite effects of FG 7142 and lorazepam. Psychopharmacology 115:350-357
10. Cole BJ, Klewer M, Jones GH, Stephens DN (1993) Contrasting effects of the competitive NMDA antagonist CPP and the non-competitive NMDA antagonist MK 801 on performance of an operant delayed matching to position task in rats. Psychopharmacology 111:465-471
11. Cotman CW, Monaghan DT, Ottersen OP, Storm-Matthisen J (1987) Anatomical organisation of excitatory amino acid receptors and their pathways. Trends Neurosci 10:273-280
12. Curtis DR, Phillis JW, Watkins JC (1959) Chemical excitation of spinal neurones. Nature 183:610-612
13. Davies J, Francis AA, Jones AW, Watkins JC (1981) 2-Amino-5-phosphonovalerate (2-APV), a potent and selective antagonist of amino-acid induced and synaptic excitation. Neurosci Lett 21:77-81
14. Danysz W, Wroblewski JT (1989) Amnesic properties of glutamate receptor antagonists. Neurosci Res Commun 479:9-18
15. Danysz W, Wroblewski JT, Costa E (1988) Learning impairment in rats by N-methyl-D-aspartate receptor antagonists. Neuropharmacology 27:653-656
16. Danysz W, Zajaczkowski W, Parsons CG (1995) Modulation of learning processes by ionotropic glutamate receptor ligands. Behav Pharmacol 6:455-474
17. Durmuller N, Craggs M, Meldrum BS (1994) The effect of the non-NMDA receptor antagonists GYK1 52466 and NBQX, and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling, and on amygdala kindled seizures. Epilepsy Res 17:167-174
18. Flood JF, Baker ML, Davis JL (1990) Modulation of memory processing by glutamic acid receptor agonists and antagonists Brain Res 521:197-202
19. Gray JA (1981) The neuropsychology of anxiety. Oxford University Press, Oxford
20. Hudzik TJ, Slifer BL (1992) Interaction of sigma and PCP-like drugs on operant behaviors in the rat. Psychopharmacology 108: 115-122
21. Izquierdo I (1994) Pharmacological evidence for an involvement of long term potentiation in memory. FASEB J 8:1139-1145
22. Jerulinsky D, Ferreira MBC, Walz R, Dasilva RC, Bianchin M, Ruschel AC, Zanatta MS, Medina JH, Izquierdo I (1992) Amnesia by post training infusion of glutamate receptor antagonists into the amygdala, hippocampus and entorhinal cortex. Behav Neural Biol 58:76-80
23. Kahneman D (1973) Attention and effort. Prentice Hall, Eaglewood Cliffs, N.J.
24. Kim M, Campeau S, Falls WA, Davis M (1993) Infusion of the non-NMDA receptor antagonist CNQX into the amygdala blocks the expression of fear potentiated startle. Behav Neural Biol 59:5-8
25. Layer RT, Uretszy NJ, Wallace LJ (1993) Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug induced conditioned place preference. Brain Res 617:267-273
26. Liang KC, Hon W, Davis M (1994) Pre- and post-training infusion of N-methyl-D-aspartate receptor antagonists into the amygdala impair memory in an inhibitory avoidance task. Behav Neurosci 108:241-253
27. Lyford GL, Jarrard LE (1991) Effects of the competitive NMDA antagonist CPP on performance of a place and cue radial maze task. Psychobiology 19:157-160
28. Misztal M, Danysz W (1995) Comparison of glutamate antagonists in continuous multiple trial and single trial dark avoidance. Behav Pharmacol 6:550-561
29. Morris RGM (1989) Synaptic plasticity and learning: selective impairment of learning in rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist, AP5. J Neurosci 9:3040-3057
30. Parada J, Czuczwar SJ, Turski WA (1992) NBQX does not affect learning and memory tasks in mice a comparison with d-CPPene and ifenprodil. Cognit Brain Res 1:67-71
31. Poling A, Cleary J, Jackson K, Wallace S (1981) d-Amphetamine and phencyclidine alone and in combination: effects on fixed ratio and inter-response-time-greater-than-t responding of rats. Pharmacol Biochem Behav 15:357-361
32. Pontecorvo MJ, Clissold DB, White MF, Ferkany JW (1991) N-Methyl-D-aspartate antagonists and working memory performance: comparison with the effects of scopolamine, propranalol, diazepam and phenylisopropyladenosine. Behav Neurosci 105:521-531
33. Quillfeldt JA, Schmitz PK, Walz R, Bianchin M, Zanatta MS, Medina JH, Izquierdo I (1994) CNQX infused into entorhinal cortex blocks memory expression, and AMPA reverses the effect. Pharmacol Biochem Behav 48:437-440
34. Ratkowsky DA (1990) Handbook of nonlinear regression models. Marcel Dekker, New York
35. Sanger DJ (1992) NMDA antagonists disrupt timing behaviour in rats. Behav Pharmacol 3:593-600
36. Sanger DJ, Blackman DE (1975) The effects of tranquillising drugs on timing behaviour in rats. Psychopharmacologia 44:153-156
37. Sanger DJ, Jackson A (1988) Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats. J Pharmacol Exp Ther 248:1215-1221
38. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honore T (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzol(F)quinoxaline a neuroprotectant for cerebral ischemia. Science 247:571-574
39. Smith SE, Darmuller N, Meldrum BS (1991) The non-N-methyl-D-aspartate receptor antagonists GYK1 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur J Pharmacol 201:179-183
40. Spencer DG, Emmett-Oglesby MW (1985) Parallel processing strategies in the application of microcomputers to the behavioral laboratory. Behav Res Methods Instrum Comput 17: 294-300
41. Stephens DN, Voet B (1994) Differential effects of anxiolytic and non-anxiolytic benzodiazepine receptor ligands on performance of a differential reinforcement of low rate (DRL) schedule. Behav Pharmacol 5:4-14
42. Stephens DN, Meldrum BS, Weidmann R, Schneider C, Grutzner M (1986) Does the excitatory amino acid antagonist 2-APH exhibit anxiolytic activity? Psychopharmacology 90:166-169
43. Stephens DN, Andrews JS, Turski L, Schneider HH (1991a) Excitatory amino acids and anxiety. In: Briley M, File SE (eds) New concepts in anxiety. Macmillan Press, Basingstoke, pp 366-381
44. Stephens DN, Duka T, Andrews JS (1991b) Benzodiazepines, β-carbolines and memory. In: Weinman J, Hunter J (eds) Memory: neurochemieal and abnormal perspectives. Harwood Academic Publishers, Chur (Switzerland), pp 11-42
45. Swedberg MDB, Jacobsen F, Honore T (1995) Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline (NBQX). J Pharmacol Exp Ther 274:1113-1121
46. Tan S, Kirk RC, Abraham WC, McNaughton N (1989) Effects of the NMDA antagonists CPP and MK-801 on delayed conditional discrimination. Psychopharmacology 98:556-560
47. Tonkiss J, Rawlins JNP (1991) The competitive NMDA receptor antagonist AP5, but not the non-competitive antagonist MK801, induces a delay-related impairment in spatial working memory in rats. Exp Brain Res 85:349-358
48. Tonkiss J, Morris RGM, Rawlins JNP (1988) Intaventricular infusion of the NMDA receptor antagonist AP5 impairs performance on a non-spatial operant DRL task in the rat. Exp Brain Res 73:181-188
49. Turski L, Jacobsen P, Honore T, Stephens DN (1992) Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate antagonist 2,3-dihydroxyy-6-nitro-7-sulfamoyl-benzo(F) quinoxaline. J Pharmacol Exp Ther 260:742-747
50. Upchurch M, Wehner JM (1990) Effects of N-methyl-D-aspartate antagonism on spatial learning in mice. Psychopharmacology 100:209-214
51. Ward L, Mason SE, Abraham WC (1990) Effects of the NMDA antagonists CPP and MK 801 on radial maze performance in rats. Pharmacol Biochem Behav 35:785-790
52. Watkins JC, Krosgaard-Larsen P, Honore T (1990) Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol Sci 11:25-33
53. Welzl H, Berz S, Battig K (1991) The effects of the non-competitive NMDA receptor antagonist MK801 on DRL performance in rats. Psychobiology 19:211-216
54. Wiley JA, Balster RL (1992) Preclinical evaluation of N-methyl-D-aspartate antagonists for antianxiety effects: a review. In: Kamenka J-M, Domino EF (eds) Multiple sigma and PCP receptor ligands: mechanisms for neuromodulation and neuroprotection. NPP Books, Ann Arbor, Michigan, pp 801-815
55. Wogar MA, Bradshaw CM, Szabadi E (1992) Impaired acquisition of temporal differentiation performance following lesions of the ascending 5-hydroxytryptaminergic pathways. Psychopharmacology 107:373-378
56. Wong EHF, Kemp JA, Priestly T, Knight AR, Woodruff GN, Iversen LL (1986) The anticonvulsant MK 801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83:7104-7108
57. Zorumski CF, Yamada KA, Price MT, Olney JW (1993) A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron 10:61-67